Hepatitis B Vaccine

Modified on 2009/10/14 21:51 by admin
Studies show that an estimated 1.25 million people in the United States carry the hepatitis B virus. It is also estimated that an additional 200,000 Americans are infected with hepatitis B each year. 11,000 of those people are hospitalized and 20,000 remain chronically infected. In addition, between 4,000 and 5,000 hepatitis B sufferers die each year due to hepatitis B-related chronic liver disease or liver cancer.

A person may become infected with hepatitis B after exposure to blood or other bodily fluids infected with the virus. Although some groups are more at risk to contract hepatitis B, exposure can occur among persons of all ages, social, or ethnic groups. Antibiotics cannot cure hepatitis B.

The hepatitis B vaccine has been effective in preventing hepatitis B. However, some studies suggest a link between the hepatitis B vaccine and serious neurological diseases or chronic illnesses, including multiple sclerosis, diabetes, chronic fatigue syndrome, rheumatoid arthritis, or optic neuritis.

In September 2004, researchers with the Harvard School of Public Health released findings from a study on the link between the hepatitis B vaccine and the development of multiple sclerosis. While the study, published in the journal Neurology, indicates that there is no direct evidence showing that the vaccine actually causes MS, data comparing UK patients with the disease to similar patients without MS reveals a three-fold risk of developing MS within three years of receiving the vaccine.

See your doctor if you are concerned about the safety of the hepatitis B vaccine. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Vaccines: Overview
  2. Diabetes
  3. Fatigue: Overview
  4. Information on Arthritis
  5. Multiple Sclerosis: Overview
  6. Optic Neuritis: Overview
  Name Size